Answers are grounded in this paper and cite their sources.
This study compared use of a single dose to two doses of a one-dose porcine circovirus type 2 (PCV2) vaccine. Two doses of the PCV2 vaccine administered at 1 and 3 weeks of age (extra-label use) provides no additional protection, compared to one dose administered at 3 weeks of age.
No takes yet. Share an insight, caveat, or question.
Seo et al. (2015) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: